These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35311666)

  • 1. Utility of the RENAL Nephrometry Scoring System in Predicting Adverse Events and Outcomes of Percutaneous Microwave Ablation of Renal Tumors.
    Li S; Huang J; Jang S; Schammel NC; Schammel C; Som A; El Khudari H; Devane AM; Gunn AJ
    J Vasc Interv Radiol; 2022 Jun; 33(6):695-701. PubMed ID: 35311666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
    Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
    J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Boorjian SA; Carter RE; Geske JR; Callstrom MR; Atwell TD
    J Urol; 2013 Jan; 189(1):30-5. PubMed ID: 23164375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between R.E.N.A.L. nephrometry score and survival outcomes in renal tumours.
    Zhang X; Sun Q; Qi Y; Chen Y; Xiong Y; Xi W; Miao Z; Li X; Quan X; Lin J
    Jpn J Clin Oncol; 2024 Mar; 54(3):339-345. PubMed ID: 38117949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma: evaluating the performance of nephrometry scores.
    Efthymiou E; Velonakis G; Charalampopoulos G; Mazioti A; Brountzos E; Kelekis N; Filippiadis D
    Eur Radiol; 2023 Nov; 33(11):7388-7397. PubMed ID: 37318604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
    Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
    Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Cell Carcinoma: Comparison of RENAL Nephrometry and PADUA Scores with Maximum Tumor Diameter for Prediction of Local Recurrence after Thermal Ablation.
    Maxwell AWP; Baird GL; Iannuccilli JD; Mayo-Smith WW; Dupuy DE
    Radiology; 2017 May; 283(2):590-597. PubMed ID: 27875105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas.
    Shakeri S; Afshari Mirak S; Mohammadian Bajgiran A; Pantuck A; Sisk A; Ahuja P; Lu DS; Raman SS
    Abdom Radiol (NY); 2019 Jun; 44(6):2308-2315. PubMed ID: 30847565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous microwave ablation of renal masses in a UK cohort.
    John JB; Anderson M; Dutton T; Stott M; Crundwell M; Llewelyn R; Gemmell A; Bufacchi R; Spiers A; Campain N
    BJU Int; 2021 Apr; 127(4):486-494. PubMed ID: 32871034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified PADUA Renal (SPARE) Nephrometry Scoring System: External Validation, Interobserver Variability, and Comparison with RENAL and PADUA in a Single-center Robotic Partial Nephrectomy Series.
    Weprin S; Falagario U; Veccia A; Nandanan N; Emerson D; Ovanez C; Albuquerque EV; Zukovski EB; Clayton R; Hampton L; Autorino R
    Eur Urol Focus; 2021 May; 7(3):591-597. PubMed ID: 32591285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal tumour nephrometry score does not correlate with the risk of radiofrequency ablation complications.
    Seideman CA; Gahan J; Weaver M; Olweny EO; Richter M; Chan D; Cadeddu JA
    BJU Int; 2013 Dec; 112(8):1121-4. PubMed ID: 24053576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External Validation of the Percutaneous Renal Ablation Complexity Scoring System in Patients Undergoing Percutaneous Cryoablation or Microwave Ablation of Renal Tumors.
    Guidry R; Macha V; Li Y; El Khudari H; Bready ER; Huang J; Caridi TM; Gunn AJ
    J Vasc Interv Radiol; 2022 Dec; 33(12):1588-1593. PubMed ID: 35998804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited ability of the renal ablation-specific (MC)2 risk scoring system to predict major adverse events from percutaneous renal microwave ablation.
    Savage CH; Devane AM; Li Y; Li M; Schammel NC; Little ME; Schammel C; Pigg RA; El Khudari H; Rais-Bahrami S; Huang J; Gunn AJ
    Clin Imaging; 2023 Aug; 100():30-35. PubMed ID: 37187107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients.
    Yu J; Zhang X; Liu H; Zhang R; Yu X; Cheng Z; Han Z; Liu F; Hao G; Mu MJ; Liang P
    Radiology; 2020 Mar; 294(3):698-706. PubMed ID: 31961239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microwave ablation of cT1a renal cell carcinoma: oncologic and functional outcomes at a single center.
    Wilcox Vanden Berg RN; Calderon LP; LaRussa S; Enobakhare O; Craig K; Del Pizzo J; McClure TD
    Clin Imaging; 2021 Aug; 76():199-204. PubMed ID: 33964597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microwave treatment of renal cell carcinoma adjacent to renal sinus.
    Gao Y; Liang P; Yu X; Yu J; Cheng Z; Han Z; Duan S; Huang H
    Eur J Radiol; 2016 Nov; 85(11):2083-2089. PubMed ID: 27776662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
    Zhou W; Arellano RS
    J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.